Connect your AI

Profound Medical PROF Earnings yield

Earnings yield at other companies

Intuitive SurgicalISRG

1.8%+0.4pp

TriSalus Life Sciences, Inc.TLSI

-11.1%-2.5pp

BioventusBVS

4.6%+3.0pp

Globus MedicalGMED

5%+3.2pp

Other financials

Income statement

Revenue$5.3M+104%

Gross profit$3.8M+107%

Operating income-$8.0M+28.2%

Net income-$7.1M+34.2%

EPS (diluted)$0.19-47.2%

Balance sheet

Cash & equivalents$50.3M+8.3%

Total debt$7.5M+52.8%

Total equity$59.4M+17.0%

Total assets$73.5M+20.7%

Cash flow

Operating cash flow-$8.6M-3.6%

CapEx$44.0K—

Free cash flow-$9.6M—

Valuation

Market cap$241.65M+30.7%

Enterprise value$198.81M+28.7%

P/S12.8×-2.8×

Profitability

Gross margin71.1%+3.4pp

Operating margin-202.6%-51.3pp

Net margin-206.8%-39.0pp

FCF margin-238.4%—

Returns & leverage

Return on equity-70.6%+4.8pp

Debt / equity0.1×0.0×

Current ratio6.6×-4.8×

Where this comes from

Calculated from Profound Medical’s reported figures.

net income/market cap=-16.5%

Based on trailing twelve months.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Profound Medical's earnings yield?: Profound Medical (PROF) reported earnings yield of -16.5% in Q1 2026.
How has Profound Medical's earnings yield changed year-over-year?: Profound Medical's earnings yield increased by 9.5% year-over-year, from -18.3% to -16.5%.
What is the long-term trend for Profound Medical's earnings yield?: Over 2 years (2023 to 2025), Profound Medical's earnings yield has grown at a -1.0% compound annual growth rate (CAGR), from -15.6% to -15.3%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.